$100M HHS ‘innovative collaboration’ to advance Medicaid reform

Laura Pedulli | | Health Exec | Economics

A new $100 million program at the Department of Health & Human Services (HHS) aims to accelerate Medicaid reform.

HHS Secretary Sylvia Burwell announced the launch of the Medicaid Innovation Accelerator Program, a federal collaborative effort with states to improve health, healthcare delivery and decrease costs through technical assistance.

Specifically, new resources developed under the program "will support state-based innovative healthcare reform efforts by identifying and advancing new Medicaid service delivery and financing models to improve patient care by providing data analytics, improving quality measurement and rapid cycle evaluation capabilities, and advancing effective and timely dissemination of best practices and learning among states," according to a release.

“Medicaid innovation is moving forward, and the new Medicaid Innovation Accelerator Program, announced in response to recommendations from governors, will give states the opportunity to even further strengthen their great work,” said Burwell. “HHS will provide strategically targeted resources that states can leverage to enhance the impact of their efforts to transform healthcare.”

Read more here.

 

Laura Pedulli

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.